Ratings Generali

Equities

G

IT0000062072

Market Closed - Borsa Italiana 11:44:59 2024-04-26 EDT 5-day change 1st Jan Change
22.8 EUR +0.18% Intraday chart for Generali +0.57% +19.34%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.
  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

  • With a P/E ratio at 9.47 for the current year and 8.77 for next year, earnings multiples are highly attractive compared with competitors.
  • With regards to fundamentals, the enterprise value to sales ratio is at 0.88 for the current period. Therefore, the company is undervalued.
  • The company has a low valuation given the cash flows generated by its activity.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The company's earnings growth outlook lacks momentum and is a weakness.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

1st Jan change Capi. Investor Rating ESG Refinitiv
+19.34% 37.78B
B
+14.78% 79.51B
B-
+6.49% 50.22B
B+
+1.35% 48.11B
B
+9.53% 42.2B
B+
+6.55% 39.71B
B+
+2.84% 30.07B
B
-7.77% 27.56B
B-
-18.42% 24.71B
A-
+6.89% 21.99B
A
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes